Hallengren tar plats i global grupp mot antibiotikaresistens

Socialministern en av 26 ledamöter i gruppen.

Pharma Outsourcing igång på Stockholm Waterfront

We are poor lobbyists

I doubt there has ever been a really well thought out Scandinavian campaign with intentions to really change attitudes among both the public and politicians.

The first drugs to slow down Alzheimer’s – but what does it mean for patients?

New treatments for early Alzheimer’s are bringing hope to thousands of patients and their families. The question is, who will get the treatment, how will the ri...

Reproducibility and handling in focus with new electronic pipette

The Eppendorf Xplorer electronic pipette has been developed with reproducibility in mind.

Column: "Are we already living in the new normal?"

2020 felt like the year that we were building the house around us whilst moving into it at the same time.

It´s time to establish relations

Communication with the patient is the key to future healthcare, writes Hanna Brodda, editor in chief of Life Science Sweden.

Martin Bergö: "The Idea is the Thing"

Martin Bergö, 38, goes wherever ideas take him - it's a process that has led to, and resulted from, plenty of unexpected results. Those ideas have been recognized as good ones: in 2008, he was awarded the Eric K. Fernström Foundation's Prize for young...

Lif vill ha "nationell ingång" för hälsodata även i Sverige

Sverige behöver förbättra tillgängligheten till hälsodata för forskning och innovation, anser branschorganisationen Lif, som tycker att vi borde snegla mot våra...

Your partnering tool - step by step

Profile, agenda and requests. Those are the basic steps to follow to use the partnering tool for Biotech Forum. Follow our guide to successful partnering!

The first vaccine derived from cowpox

The British rural doctor could not forget the words of the peasant girl. Could that really be true? A couple of decades later, on 14 May 1796, he performed the ...

Anna Törner: To kill your darlings

Hopes were high when Anna Törner and her colleague started a study on a dietary supplement that seemed unbelievably good. “Enthusiastically, we dreamed of excit...

Cate Poulsen, Qiagen

Why are you going to Scanlab and Biotech Forum?

Swedish Healthtech Company 1928 Pushing Forward

The full service analytics platform is expanding the business.

Rätt läkemedel till rätt patient – ett paradigmskifte på väg

Ett nytt sätt att se på läkemedel mot cancer har gjort sitt intåg – läkemedel som förskrivs vid en viss genmutation istället för vid en viss cancersjukdom. Det ...

Samuel Lagercrantz: Immunotherapy against cancer is still in its early stages

For more than 100 years, researchers have tried to target the body’s own immune system to fight cancer cells. They have occasionally been laughed at and ridicul...

From planning stage to handshake

"Partnering is an effective tool to get in touch with the decision makers high up in an organization's administration," says Camilla Huse Bondeson at Conlega. A...

Coordination of world-class research facilities

Four unique world-class research facilities are located just a few hours apart. Properly utilised, a Nordic centre for world-leading life science innovation and...

Brexit looking back and looking forward

More than 3 years have passed after the vote and there is still uncertainty around the outcome although the UK December 12 election set a clearer course towards...

Will the industry follow the economic revival?

Welcome to the eleventh Biotech Forum + Scanlab Fair!

Teams up with leading dermatologist

Tripep has signed a letter of intent with a major Japanese specialty pharma company to bring their wound healing treatment to a big market.

The perfect formula for decision-making

No one has the luxury not to take a decision, writes Helena Strigård at Swedenbio.

How critical are the “Spermageddon” reports? – Researchers call for action

A much talked about meta-study indicates that sperm concentration in men’s seminal fluid has halved in 40 years. Experts in andrology that Life Science Sweden s...

Pilots want to live too